Human lactoferrin is an iron-binding glycoprotein that is particularly prom
inent in exocrine secretions and leukocytes and is also found in serum, esp
ecially during inflammation, It is able to sequester iron from microbes and
has immunomodulatory functions, including inhibition of both complement ac
tivation and cytokine production. This study used mutants lacking pneumococ
cal sur face protein A (PspA) and PspC to demonstrate that the binding of h
uman lactoferrin to the surface of Streptococcus pneumoniae was entirely de
pendent on PspA, Lactoferrin bound both family 1 and family 2 PspAs. Bindin
g of lactoferrin to PspA was shown by surface colocalization with PspA and
was verified by the lack of binding to PspA-negative mutants, Lactoferrin w
as expressed on the body of the cells but was largely absent from tile pole
s. PspC showed exactly the same distribution on the pneumococcal surface as
PspA but did not bind lactoferrin, PspA's binding site for lactoferrin was
mapped using recombinant fragments of PspA of families 1 and 2, Binding of
human lactoferrin was detected primarily in the C-terminal half of the a-h
elical domain of PspA (amino acids 167 to 288 of PspA/Rx1), with no binding
to the N-terminal 115 amino acids in either strain. The interaction was hi
ghly specific. As observed preciously, bovine lactoferrin bound poorly to P
spA. Human transferrin did not bind PspA at all. The binding of lactoferrin
to S, pneumoniae might provide a way for the bacteria to interfere with ho
st immune functions or to aid in the acquisition of iron at the site of inf
ection.